Vanguard Group Inc Immunity Bio, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IBRX
# of Institutions
216Shares Held
63.3MCall Options Held
1.43MPut Options Held
4.12M-
Black Rock Inc. New York, NY11.4MShares$42.4 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$29.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$14.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$6.37 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.58MShares$5.85 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.49B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...